About Dr. Haseltine
Dr. Katherine Noto Haseltine is an Endocrinologist in the Metabolic Bone division at HSS. She is board certified in Endocrinology, Diabetes, and Metabolism, as well as Internal Medicine.
Dr. Haseltine received her undergraduate degree from Duke University and completed her medical degree at Weill Cornell Medical College. She completed her residency in internal medicine at Brown University followed by her endocrinology fellowship at Weill Cornell Medicine, where her training was divided between NewYork-Presbyterian Hospital, Memorial Sloan Kettering Cancer Center, and Hospital for Special Surgery. She then went on to complete a metabolic bone fellowship at Hospital for Special Surgery for specialized training in both clinical management and research in metabolic bone diseases.
Departments
Internal Medicine
Endocrinology
Specialized Centers
Osteoporosis and Metabolic Bone Health
Patient Stories
Insurance
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Credentials
Appointments
Assistant Attending Physician, Hospital for Special Surgery
Assistant Professor of Clinical Medicine, Weill Cornell Medical College
Assistant Attending, NewYork-Presbyterian Hospital
Certification
Internal Medicine
Endocrinology, Diabetes, and Metabolism
Education
Weill Cornell Medical College, 2015
Internship
Brown University, 2016
Residency
Brown University, 2018
Fellowship
NewYork-Presbyterian/Weill Cornell Medical Center, 2020
Memorial Sloan Kettering Cancer Center, 2020
Hospital for Special Surgery, 2021
State Licensure
Languages
English
Publications by Dr. Haseltine
Research
Industry Relationships
Industry Relationships
HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.
As of April 10, 2023, Dr. Haseltine reported no relationships with the healthcare industry.
HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.